Sequencing Used to Identify Delta, Other Coronavirus Variants
SciCheck Digest
Researchers use genomic sequencing — not the clinical tests used to diagnose patients with COVID-19 — to identify and track specific variants of the novel coronavirus, SARS-CoV-2, including the highly contagious delta variant. But viral posts try to deny the existence of the variant by misleadingly claiming there is “no ‘Delta Variant’ test.”
Tests that detect current infections with SARS-CoV-2, the virus that causes COVID-19, are known as viral tests. There are two types: a Nucleic Acid Amplification Test, or NAAT, and an antigen test. Many of the NAATs use a molecular biology technique known as the polymerase chain reaction, or PCR, to detect even a very tiny amount of the virus in a specimen. The PCR test takes advantage of some natural features of biology to essentially scan through all of the RNA present in a sample — such as a nasal swab — and search for the presence of coronavirus RNA. The Centers for Disease Control and Prevention NAATs “are unlikely to return a false-negative result of SARS-CoV-2,” and it recommends only laboratory-based NAATS, the most saliva tests aren’t as optimal as those using swabs of the nose or nasopharynx (upper throat behind the nose).
You’re reading a preview, subscribe to read more.
Start your free 30 days